查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629216

血液动力学流量改变设备市场，按类型、应用、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Hemodynamic Flow Alteration Devices Market, By Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 395 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年，血流动力学改变装置市场规模为 8.0567 亿美元，2024 年至 2032 年复合年增长率为 8.5%。

血流动力学流量改变装置市场-市场动态

包括心臟衰竭和缺血性心臟病在内的心血管疾病盛行率不断上升，推动市场需求

心血管疾病（CVD），特别是心臟衰竭和缺血性心臟病的盛行率不断增加，推动了对血流动力学改变装置的需求不断增长。随着人口老化，心臟衰竭和缺血性心臟病的发生率持续上升。据世界卫生组织 (WHO) 称，CVD 是全球主要死亡原因，约占全球死亡总数的 32%。心臟病负担的增加迫切需要支持心臟功能并提高患者存活率的医疗设备。心室辅助装置 (VAD)、主动脉内球囊反搏帮浦 (IABP) 和体外膜氧合 (ECMO) 等设备对于在危急情况下稳定患者并增强循环至关重要。这些设备可防止器官衰竭、提供氧合併提供机械支持，为患者提供恢復或更明确治疗所需的时间。此外，这些技术的进步使设备更加有效和易于使用，从而进一步提高了它们的采用率。对这些设备的需求不断增长，是因为迫切需要解决全球日益增长的心血管负担，尤其是心血管疾病仍然是第一大死因，每年影响数百万人。

血流动力学流量改变设备市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.5% 左右的复合年增长率成长
  • 根据类型细分，预计慢性完全封堵器将在 2023 年显示最大的市场份额
  • 从应用细分来看，心臟器械是2023年的主导类型
  • 按地区划分，北美是 2023 年的主要收入来源

血流动力学流量改变装置市场区隔分析：

全球血流动力学改变设备市场根据类型、应用、最终用途和地区进行细分。

市场依类型分为两类：栓塞防护装置和慢性完全闭塞装置。慢性完全闭塞装置在市场上占据主导地位，因为它在治疗无法透过标准血管成形术解决的复杂冠状动脉阻塞患者方面发挥关键作用。冠状动脉疾病的盛行率不断上升，加上对微创手术的需求不断增长，推动了 CTO 设备的采用，该设备可显着改善患者的治疗结果，并降低併发症发生率。

市场依应用分为三类：心臟设备、脑流设备及週边循环设备。心臟器材在市场上占据主导地位，并且由于冠状动脉疾病、心臟衰竭和心律不整等心血管疾病的盛行率不断增加，需要先进的医疗干预措施来改善患者的预后，因此在预测期内可能会保持其主导地位。

血流动力学改变装置市场 - 地理洞察

在医疗保健需求不断增长和技术进步的推动下，不同地区的血流动力学流量改变装置市场正在经历显着增长。北美，特别是美国，由于医疗保健支出高、人口老化程度高以及先进医疗技术的采用增多，在市场上占据主导地位。该地区强大的医疗基础设施支援心室辅助装置 (VAD)、主动脉内球囊反搏泵 (IABP) 和体外膜氧合 (ECMO) 系统等设备的广泛使用。欧洲也呈现强劲的成长潜力，德国、英国和法国等国家投资于医疗保健创新，导致这些救生设备的采用率增加。由于心血管疾病盛行率不断上升、医疗保健服务范围不断扩大以及医疗旅游业的成长，亚太地区预计将在预测期内实现最高的成长率。日本、中国和印度等国家正在以越来越快的速度采用这些设备，政府措施和改善医疗基础设施促进了市场的扩张。人们对心臟病的认识不断提高以及该领域的技术进步可能会继续推动全球血流动力学改变装置的采用。

血流动力学流量改变装置市场-竞争格局：

血液动力学流量改变装置市场的竞争格局的特点是存在几个专注于创新、策略合作伙伴关係和地理扩张以维持其市场地位的关键参与者。公司越来越多地投资于研发，以提高其设备的效率和有效性，特别强调透过侵入性更小、更用户友好的解决方案来改善患者的治疗结果。除了产品创新之外，合併、收购和合作也是扩大产品组合和进入新市场的常见策略。市场上还看到，来自提供穿戴式装置和远端监控解决方案等先进技术的公司的竞争日益激烈，这些技术由于其便利性以及与数位健康平台的整合而受到关注。此外，医疗保健提供者和机构正在成为采用这些设备的关键决策者，随着公司寻求展示其产品的临床效益、成本效益和长期优势，从而推动竞争。随着全球对血流动力学支援设备的需求持续成长，竞争动态也将发生变化，各公司将专注于提供解决急性和慢性心血管疾病的综合解决方案。

最新进展：

  • 2022 年 2 月，飞利浦透过整合脉衝波多普勒增强了 Lumify 手持式超音波系统，使医疗保健专业人员能够即时评估血流动力学和血流，从而提高各个医疗专业的诊断能力。脉衝波多普勒的加入，与B-lines 软体等其他先进功能相结合，扩展了Lumify 的实用性，能够更快、更准确地评估心臟、肺和血管状况，特别是在紧急情况等护理点环境中和产科护理。
  • 2024 年 6 月，Elixir Medical 的 DynamX Bioadaptor 系统被授予 FDA 突破性设备称号，从而可以更有效地进行监管审查。该系统旨在改善缺血性心臟病患者的冠状动脉管腔直径、恢復血流动力学调节并减少斑块进展，如最近的试验结果所示，与目前的治疗方案相比，具有显着的优势。
  • 2022年5月，乔治亚理工学院的研究人员开发了一种无线植入式血管监测系统，由智慧支架和能够即时血流动力学监测的印刷软式感测器组成。这种创新设备无需电池或传统电路即可提供动脉压、脉搏和血流的连续资料，旨在改善高血压和动脉粥样硬化等血管疾病的诊断和治疗，同时有可能取代昂贵的侵入性成像技术。

目录

第 1 章：血流动力学流量改变装置市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的血流动力学流量改变设备市场片段
    • 血流动力学流量改变设备市场片段（依应用）
    • 依最终用途分類的血流动力学流量改变装置市场片段
    • 按国家/地区分類的血流动力学流量改变设备市场片段
    • 按地区分類的血流动力学改变装置市场片段
  • 竞争洞察

第 3 章：血流动力学流量改变装置主要市场趋势

  • 血流动力学流量改变设备市场驱动因素
    • 市场驱动因素的影响分析
  • 血流动力学改变装置市场限制
    • 市场限制影响分析
  • 血流动力学改变装置的市场机会
  • 血流动力学改变装置市场未来趋势

第 4 章：血液动力学流量改变装置产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：血流动力学流量改变设备市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：血流动力学流量改变装置市场格局

  • 2023 年血流动力学改变装置市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：血流动力学流量改变设备市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 栓塞防护装置
    • 慢性全闭塞装置

第 8 章：血流动力学流量改变设备市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 心臟装置
    • 脑流设备
    • 末梢循环装置

第 9 章：血流动力学流量改变设备市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 门诊手术中心
    • 医院和诊所

第 10 章：血流动力学流量改变设备市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美地区血流动力学改变装置的主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲血流动力学改变装置的主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区血流动力学改变装置主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲血流动力学改变装置的主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲血流动力学改变装置的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 血液动力学流量改变设备产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abiomed, Inc.
    • Medtronic, Inc.
    • Teleflex Incorporated
    • Edwards Lifesciences Corporation
    • Getinge Group
    • Fresenius Medical Care AG & Co. KGaA
    • LivaNova PLC
    • CardiacAssist, Inc.
    • Terumo Corporation
    • BiVACOR, Inc.
    • SynCardia Systems, LLC
    • Johnson & Johnson
    • Boston Scientific Corporation
    • Philips Healthcare
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4552

REPORT HIGHLIGHT

Hemodynamic Flow Alteration Devices Market size was valued at USD 805.67 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

Hemodynamic flow alteration devices are medical devices designed to modify or support blood circulation in patients with compromised hemodynamic function. These devices include intra-aortic balloon pumps (IABPs), ventricular assist devices (VADs), extracorporeal membrane oxygenation (ECMO), and various vascular grafts and stents. They are primarily used in patients with heart failure, shock, or those undergoing complex surgeries where maintaining optimal blood flow is critical. The need for these devices arises from the increasing prevalence of cardiovascular diseases, which require advanced interventions to sustain life, improve circulation, and support organs until they recover or until more definitive treatment is performed. The importance of hemodynamic flow alteration devices is underscored by their ability to provide temporary circulatory support, thus preventing organ failure and improving survival rates. Additionally, these devices are essential in critical care settings, where they help stabilize patients, provide oxygenation, and reduce the strain on the heart, allowing time for healing or recovery

Hemodynamic Flow Alteration Devices Market- Market Dynamics

Increasing prevalence of cardiovascular diseases, including heart failure and ischemic heart conditions to propel market demand

The increasing prevalence of cardiovascular diseases (CVD), particularly heart failure and ischemic heart conditions, is driving the growing demand for hemodynamic flow alteration devices. As populations age, the incidence of heart failure and ischemic heart disease continues to rise. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for approximately 32% of all deaths worldwide. This increasing burden of heart disease creates an urgent need for medical devices that support heart function and improve patient survival. Devices like ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) are crucial in stabilizing patients and enhancing circulation in critical situations. These devices prevent organ failure, provide oxygenation, and offer mechanical support, giving patients the time they need for recovery or more definitive treatment. Furthermore, advancements in these technologies are making devices more effective and accessible, further increasing their adoption. The rising demand for these devices is driven by the urgent need to address the growing global cardiovascular burden, highlighted by the fact that CVD remain the number one cause of death, impacting millions of individuals annually.

Hemodynamic Flow Alteration Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)
  • Based on Type segmentation, Chronic Total Occlusion Device was predicted to show maximum market share in the year 2023
  • Based on Application segmentation, Cardiac Devices was the leading type in 2023
  • Based on region, North America was the leading revenue generator in 2023

Hemodynamic Flow Alteration Devices Market- Segmentation Analysis:

The Global Hemodynamic Flow Alteration Devices Market is segmented based on Type, Application, End-Use and Region.

The market is divided into two categories based on type: Embolic Protection Device, and Chronic Total Occlusion Device. The Chronic Total Occlusion Device dominate the market due to its critical role in treating patients with complex coronary artery blockages that cannot be addressed through standard angioplasty. The increasing prevalence of coronary artery disease, coupled with the growing demand for minimally invasive procedures, drives the adoption of CTO devices, which offer significant improvements in patient outcomes and are associated with lower complication rates.

The market is divided into three categories based on Application: Cardiac Devices, Cerebral Flow Devices, and Peripheral Circulation Devices. Cardiac Devices dominate the market and are likely to maintain their dominance during the forecast period due to the increasing prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias, which require advanced medical interventions to improve patient outcomes.

Hemodynamic Flow Alteration Devices Market- Geographical Insights

The hemodynamic flow alteration devices market is experiencing significant growth across different regions, driven by rising healthcare needs and technological advancements. North America, particularly the United States, holds a dominant position in the market due to high healthcare spending, a large ageing population, and increased adoption of advanced medical technologies. The region's robust healthcare infrastructure supports the widespread use of devices such as ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) systems. Europe also presents strong growth potential, with countries like Germany, the UK, and France investing in healthcare innovations, leading to increased adoption of these life-saving devices. The Asia-Pacific region is expected to experience the highest growth rate during the forecast period, driven by the growing prevalence of cardiovascular diseases, expanding healthcare access, and a rise in medical tourism. Countries like Japan, China, and India are adopting these devices at a growing rate, with government initiatives and improving healthcare infrastructure contributing to the market's expansion. The rising awareness of heart diseases and technological advancements in the field are likely to continue driving the adoption of hemodynamic flow alteration devices globally.

Hemodynamic Flow Alteration Devices Market- Competitive Landscape:

The competitive landscape of the hemodynamic flow alteration devices market is characterized by the presence of several key players focusing on innovation, strategic partnerships, and geographic expansion to maintain their market position. Companies are increasingly investing in research and development to enhance the efficiency and effectiveness of their devices, with a particular emphasis on improving patient outcomes through less invasive and more user-friendly solutions. In addition to product innovation, mergers, acquisitions, and collaborations are common strategies to expand product portfolios and enter new markets. The market is also seeing increased competition from companies offering advanced technologies like wearable devices and remote monitoring solutions, which are gaining traction due to their convenience and integration with digital health platforms. Furthermore, healthcare providers and institutions are becoming key decision-makers in the adoption of these devices, driving competition as companies seek to demonstrate the clinical benefits, cost-effectiveness, and long-term advantages of their offerings. As the demand for hemodynamic support devices continues to rise globally, the competitive dynamics will evolve, with companies focusing on delivering comprehensive solutions that address both acute and chronic cardiovascular conditions.

Recent Developments:

  • In February 2022, Philips enhanced its Lumify handheld ultrasound system by incorporating Pulse Wave Doppler, allowing healthcare professionals to assess hemodynamics and blood flow in real time, improving diagnostic capabilities across various medical specialities. The addition of Pulse Wave Doppler, combined with other advanced features like B-lines software, expands the utility of Lumify, enabling faster, more accurate assessments of heart, lung, and vascular conditions, especially in point-of-care settings such as emergency and obstetric care.
  • In June 2024, Elixir Medical's DynamX Bioadaptor System was granted FDA Breakthrough Device designation, which allows for more efficient regulatory review. The system aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with ischemic heart disease, demonstrating significant benefits over current treatment options, as seen in recent trial results.
  • In May 2022, Georgia Tech researchers developed a wireless, implantable vascular monitoring system, which consists of a smart stent and printed soft sensors capable of real-time hemodynamic monitoring. This innovative device provides continuous data on arterial pressure, pulse, and blood flow without the need for batteries or traditional circuits, aiming to improve the diagnosis and treatment of vascular diseases, such as hypertension and atherosclerosis, while potentially replacing costly and invasive imaging techniques.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abiomed, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Getinge Group
  • Fresenius Medical Care AG & Co. KGaA
  • LivaNova PLC
  • CardiacAssist, Inc.
  • Terumo Corporation
  • BiVACOR, Inc.
  • SynCardia Systems, LLC
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Philips Healthcare
  • Others

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Embolic Protection Device
  • Chronic Total Occlusion Device
  • Others

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Devices
  • Cerebral Flow Devices
  • Peripheral Circulation Devices

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Ambulatory Surgical Centers
  • Hospitals & Clinics

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemodynamic Flow Alteration Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemodynamic Flow Alteration Devices Market Snippet by Type
    • 2.1.2. Hemodynamic Flow Alteration Devices Market Snippet by Application
    • 2.1.3. Hemodynamic Flow Alteration Devices Market Snippet by End-Use
    • 2.1.4. Hemodynamic Flow Alteration Devices Market Snippet by Country
    • 2.1.5. Hemodynamic Flow Alteration Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemodynamic Flow Alteration Devices Key Market Trends

  • 3.1. Hemodynamic Flow Alteration Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemodynamic Flow Alteration Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemodynamic Flow Alteration Devices Market Opportunities
  • 3.4. Hemodynamic Flow Alteration Devices Market Future Trends

4. Hemodynamic Flow Alteration Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemodynamic Flow Alteration Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemodynamic Flow Alteration Devices Market Landscape

  • 6.1. Hemodynamic Flow Alteration Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemodynamic Flow Alteration Devices Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Embolic Protection Device
    • 7.1.3. Chronic Total Occlusion Device

8. Hemodynamic Flow Alteration Devices Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Cardiac Devices
    • 8.1.3. Cerebral Flow Devices
    • 8.1.4. Peripheral Circulation Devices

9. Hemodynamic Flow Alteration Devices Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2. Ambulatory Surgical Centers
    • 9.1.3. Hospitals & Clinics

10. Hemodynamic Flow Alteration Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hemodynamic Flow Alteration Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Hemodynamic Flow Alteration Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abiomed, Inc.
    • 11.2.2. Medtronic, Inc.
    • 11.2.3. Teleflex Incorporated
    • 11.2.4. Edwards Lifesciences Corporation
    • 11.2.5. Getinge Group
    • 11.2.6. Fresenius Medical Care AG & Co. KGaA
    • 11.2.7. LivaNova PLC
    • 11.2.8. CardiacAssist, Inc.
    • 11.2.9. Terumo Corporation
    • 11.2.10. BiVACOR, Inc.
    • 11.2.11. SynCardia Systems, LLC
    • 11.2.12. Johnson & Johnson
    • 11.2.13. Boston Scientific Corporation
    • 11.2.14. Philips Healthcare
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us